Good News For Lung Cancer Patients

An FDA advisory committee (ODAC) has recommended that IRESSA be approved for treatment of advanced lung cancer that has progressed, despite chemotherapy. Studies have shown positive results in non small cell lung cancer patients given this agent. We will be watching for the

FDA to give its approval shortly and of course when this happens we will report it to you at once.

Webmaster

October 01, 2002